Magnetic Pathogen Capture for Rapid Identification and Susceptibility Testing

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current antibiotic susceptibility testing methods are lengthy due to the need for blood and pure cultures, which are inhibited by blood components and residual antibiotics, and require pathogen growth to reach saturation, making it difficult to shorten the time without compromising accuracy.

Innovation Solution

A method that isolates and concentrates pathogens using magnetic capture beads coated with specific molecules, allowing for real-time monitoring and culture optimization, eliminating the need for blood culture and enabling rapid pathogen identification and susceptibility testing.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Quantity of substance

If blood culture and pure culture processes are used for pathogen isolation, then pathogen concentration reaches saturation level (10^8 CFU/ml), but testing time extends to at least two days

Engineering Contradiction:
Improvepathogen concentrationVSAvoidtesting time
Core Design Contradiction:
Quantity of substanceVSLoss of time

Solution Approach 1:

The patent extracts and removes blood components and residual antibiotics from the patient sample using magnetic capture beads coated with specific molecules. This extraction eliminates the inhibitory factors that normally prevent pathogen growth in whole blood, allowing direct culture without the traditional blood culture step while still achieving sufficient pathogen concentration for testing.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent performs preliminary purification and concentration of pathogens from whole blood using magnetic capture beads before culture. By removing inhibitory substances in advance and concentrating the pathogen population, the system enables direct culture of isolated pathogens without requiring the extended blood culture period traditionally needed to overcome blood component interference.

Inventive Principle:
Principle #10Preliminary action

2Productivity

If blood components and residual antibiotics are present in the sample, then direct testing can be performed, but pathogen growth is inhibited

Engineering Contradiction:
Improvetesting speedVSAvoidpathogen growth
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The patent uses magnetic capture beads coated with specific molecules that selectively bind to and remove blood components and residual antibiotics. By converting the harmful inhibitory substances into removable targets, the system eliminates the conflict between using whole blood for direct testing and maintaining pathogen growth, allowing both rapid testing and reliable pathogen cultivation.

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

3Quantity of substance

If pathogen concentration is increased from 10 CFU/ml to 10^8 CFU/ml through division, then sufficient pathogen is available for testing, but culture time increases due to different division cycles

Engineering Contradiction:
Improvepathogen concentrationVSAvoidculture time
Core Design Contradiction:
Quantity of substanceVSDuration of action of moving object

Solution Approach 1:

The patent uses magnetic capture beads to concentrate multiple pathogen particles from the original sample into a small volume. This copying/concentration approach allows the system to achieve sufficient pathogen concentration for testing without requiring extended culture periods for low-initial-concentration samples, as the magnetic concentration step effectively multiplies the local pathogen density immediately.

Inventive Principle:
Principle #26Copying

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enables rapid and accurate antibiotic susceptibility testing by isolating and culturing pathogens under optimal conditions, reducing testing time and minimizing interference from blood components, thus facilitating timely antibiotic administration.

Implementation Method 1

isolates and concentrates pathogens using magnetic capture beads coated with specific molecules

Methodology Applied
Scientific EffectMagnetic separation: Magnetic Field

Data Source

PatentEP4624587A1Rapid antibiotic susceptibility test and identification method
Publication Date: 2025.10.01 QUANTA MATRIX INC
  • EP4624587A1 patent drawingFigure 1
  • EP4624587A1 patent drawingFigure 2a~2e
  • EP4624587A1 patent drawingFigure 3a~3j

AI summary

The present invention relates to a rapid antibiotic susceptibility test and an identification method capable of rapidly providing information on antibiotics suitable for microorganisms by performing an antibiotic susceptibility test and an identification test in a single process. The present invention provides a rapid antibiotic susceptibility test and an identification method comprising the steps of: (a) transferring a sample taken from a patient to a first reaction space in which a sample separation means is present; (b) separating and concentrating the pathogen in the sample from the patient's sample by capturing them with the separation means within the first reaction space; and (c) performing the identification of the pathogen or an antibiotic susceptibility test.